Ground Truth
Inclusion Criteria ComBaCaL-TwiC 1:Participant of the ComBaCaL cohort study (signed informed consent available)Living with aHT, defined as reporting intake of antihypertensive medication or being newly diagnosed during screening via standard diagnostic algorithmBP ≥140/90 mmHg at baselineInclusion criteria ComBaCaL-TwiC 2Participant of the ComBaCaL cohort study (signed informed consent available)Reporting intake of antihypertensive medicationBP<140/90 mmHg at baselineExclusion Criteria for both ComBaCaL-TwiC 1&2:Reported pregnancy (at baseline or during follow-up)
Prediction
Inclusion Criteria ComBaCaL-TwiC 1:
- Participant of the ComBaCaL cohort study (signed informed consent available)
- Living with aHT, defined as reporting intake of antihypertensive medication or being newly diagnosed during screening via standard diagnostic algorithm
- BP ≥140/90 mmHg at baseline
Inclusion Criteria ComBaCaL-TwiC 2:
- Participant of the ComBaCaL cohort study (signed informed consent available)
- Reporting intake of antihypertensive medication
- BP <140/90 mmHg at baseline
Exclusion Criteria for both ComBaCaL-TwiC 1 & 2:
- Severe comorbidity with an estimated life-expectancy of less than one year
- Reported pregnancy (at baseline or during follow-up)